المؤلفون: Ceci C., Lacal P. M., Barbaccia M. L., Mercuri N. B., Graziani G., Ledonne A.

المساهمون: Ceci, C, Lacal, Pm, Barbaccia, Ml, Mercuri, Nb, Graziani, G, Ledonne, A

مصطلحات موضوعية: Alzheimer’s disease, Angiogenesis, Axitinib, PubChem CID: 6450551, Cabozantinib, PubChem CID: 25102847, Lenvatinib, PubChem CID: 9823820, Parkinson’s disease, Pazopanib, PubChem CID: 10113978, Ponatinib: PubChem CID 24826799, Regorafenib, PubChem CID: 11167602, Sorafenib, PubChem CID: 216239, Sunitinib, PubChem CID: 5329102, VEGF-A, VEGFR-1, VEGFR-2, Vandetanib, PubChem CID: 3081361, Settore BIO/14, Settore BIOS-11/A - Farmacologia

Relation: info:eu-repo/semantics/altIdentifier/pmid/38336311; info:eu-repo/semantics/altIdentifier/wos/WOS:001185805600001; volume:201; journal:PHARMACOLOGICAL RESEARCH; https://hdl.handle.net/2108/391545

الاتاحة: https://hdl.handle.net/2108/391545
https://doi.org/10.1016/j.phrs.2024.107101